The Continued Evolution of Prostate Cancer Screening

New data will offer a unique insight into whether prostate MRI could be the test that we are looking for to preferentially detect those cancers which will benefit from treatment, whilst minimising over-detection and overtreatment which can only cause harm. The first attempt at prostate cancer screening assessed nearly 6000 men with annual digital rectal […]

Read More… from The Continued Evolution of Prostate Cancer Screening

UK Mouth Cancer Rates Hit Record High

New cases of mouth cancer in the United Kingdom have risen to a record high, according to the findings of a new report. Figures collected by the Oral Health Foundation show that 8,337 people in the UK were diagnosed with the disease last year. This has increased by nearly two-thirds (64%) since 2007. New cases […]

Read More… from UK Mouth Cancer Rates Hit Record High

Rise in Liver Cancer Diagnoses in UK Driven by Alcohol and Obesity

The British Liver Trust has warned that damage to the liver caused by alcohol and unhealthy lifestyles is leading to an increase in liver cancer diagnoses in the UK. In just ten years, the incidence of liver cancer has increased by 60% and currently 16 people every day are diagnosed with the disease. Most cases […]

Read More… from Rise in Liver Cancer Diagnoses in UK Driven by Alcohol and Obesity

Inaugural London Global Cancer Week

The inaugural London Global Cancer Week will launch at the Royal Society of Medicine on Monday 25 November. The week-long series of discussions and events will examine the impact of the rising global incidence of cancer, the challenges the cancer pandemic poses to the implementation of universal health coverage and the contribution of UK partners […]

Read More… from Inaugural London Global Cancer Week

New Evolution-busting Drug Overcomes Resistance in Aggressive Breast Cancers

A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown. Scientists at The Institute of Cancer Research, London, found that the drug could reinvigorate the response to chemotherapy in cancers that had become resistant, in both […]

Read More… from New Evolution-busting Drug Overcomes Resistance in Aggressive Breast Cancers

Gut Bacteria “Fingerprint” Predicts Radiotherapy Side Effects

· First clinical study to show link between types of gut bacteria and radiotherapy-induced gut damage · Studying patients’ bacterial fingerprint could help predict, prevent or treat gut damage following radiotherapy Taking a ‘fingerprint’ of the mix of bacteria in the gut can indicate how susceptible individual cancer patients are to gut damage as a […]

Read More… from Gut Bacteria “Fingerprint” Predicts Radiotherapy Side Effects

Olaparib Outperforms Targeted Hormone Therapy in Men with Advanced Prostate Cancer

A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings reveal. The PROfound trial compared the genetically targeted cancer drug olaparib – already licensed for women with breast and ovarian cancer who have BRCA […]

Read More… from Olaparib Outperforms Targeted Hormone Therapy in Men with Advanced Prostate Cancer

Light Activated Metal Catalyst Destroys Cancer Cells’ Vital Energy Source

New Iridium compounds effective towards killing cancer cells even without the presence of oxygen – expanding the range of tumours that can be targeted When activated by light, compound cuts off the cancer cell’s ‘power source’ Technique could reduce side effects of cancer treatment and potentially immunise against future cancer Most Iridium is believed to […]

Read More… from Light Activated Metal Catalyst Destroys Cancer Cells’ Vital Energy Source

Precision Medicine for Children with Cancer

NHS pilot found half of children had mutations in their tumours that would be targetable by drugs available for adults Those children who did receive targeted treatments saw significant benefits But only 7 per cent of children with ‘clinically actionable’ mutations could access appropriate drugs, partly due to regulatory and funding barriers, and lack of […]

Read More… from Precision Medicine for Children with Cancer

Charity Calls for Specific Policy Target for Lowest Survival Rate Cancers

A newly published study (Lancet Oncology) reveals that cancer patients in the UK still face worse survival rates than other comparable high-income countries. Pancreatic Cancer Action is calling for specific policy targets for pancreatic cancer as survival rates for the disease are particularly poor. In general, five-year cancer survival is improving across all the countries […]

Read More… from Charity Calls for Specific Policy Target for Lowest Survival Rate Cancers